You Searched For "mrna stock price" and got 20 results
Sort By:
1 min read
Moderna and Novavax pare losses after Supreme Court strikes down Biden's vaccine mandate for private employers
The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …
Carla Mozée
1 min read
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue
The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…
Matthew Fox
2 mins read
Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects
The EU's drug regulator is looking at reports about skin rash and kidney problems.
Carla Mozée
2 mins read
Moderna slides 7% even as FDA confirms vaccine's effectiveness and safety
The decline comes with Moderna's stock having surged 693% year-to-date through Monday's close.
Ben Winck
1 min read
Moderna climbs 12% after saying its coronavirus vaccine likely protects against new strains found in the UK and South Africa
Moderna stock jumped after the biotech company said its COVID-19 vaccine can likely protect against…
Emily Graffeo
1 min read
Moderna sinks 6% as investors continue to secure profits from massive vaccine rally
Moderna is awaiting FDA authorization after a panel of experts recommended the vaccine be approved …
Emily Graffeo
2 mins read
Moderna climbs 7% as Morgan Stanley says it could fill a vaccine-demand void left by Pfizer
Morgan Stanley said on Tuesday that Moderna may provide the vast majority of COVID-19 vaccine doses…
Emily Graffeo
2 mins read
Moderna stock plummeted on Biden's support of waiving vaccine patent protections, but that backing won't have a material impact on the company, Morgan Stanley says
"Any new manufacturing operation could take 6-9 months to scale," said Morgan Stanley about compani…
Carla Mozée
2 mins read
Retail purchases of Moderna and Pfizer stock hit an 8-month high as Delta infections accelerate
Individual investors have bought a combined $180 million of stock in the COVID vaccine makers in re…
Carla Mozée
1 min read
These are the 5 scientists and executives getting the richest off Moderna's spike to record highs
The biotech company's shares launched as much as 30% higher on Monday after it revealed its coronav…
Ben Winck
2 mins read
Moderna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says
Goldman Sachs raised the vaccine's probability of success to 75% from 70% and projected phase-two s…
Ben Winck
2 mins read
Moderna skyrockets 16% to record high after FDA clears coronavirus vaccine for phase 2 study
The biotech firm aims to start a phase 3 study in the summer and begin marketing the drug as early …
Ben Winck
1 min read
Translate Bio soars 30% after Sanofi agrees to buy the mRNA company for $3.2 billion
The deal represents a 56% premium to Translate Bio's volume-weighted average price per share over t…
Matthew Fox
1 min read
Moderna skyrockets 39% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients
The company is aiming to have its coronavirus drug ready for emergency use in the fall, a breakneck…
Carmen Reinicke
2 mins read
A Harvard medical professor is now a billionaire after his early stake in Moderna soared 17,000%
Timothy Springer invested $5 million in the biotech company early on, and his stake has since swell…
Ben Winck
1 min read
Moderna pops, then drops after it says booster shot increases protection against Omicron
A third dose of Moderna's booster vaccine resulted in a 37-fold increase in antibody protection aga…
Matthew Fox
1 min read
Moderna extends 2-day gain to 32% after it says Omicron vaccine will be ready in early 2022
"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really…
Matthew Fox
2 mins read
'From unreasonable to ridiculous': Here's why Moderna is set to fall 76%, according to Bank of America
"To justify $200 billion in value, one has to assume 1 to 1.5 billion doses of COVID-19 vaccine eac…
Matthew Fox
2 mins read
Moderna spikes 19% amid a flood of encouraging vaccine news, surpassing Merck in market value
Moderna, the almost 11 year old company that created a 95% effective pandemic ending vaccine in les…
Matthew Fox
1 min read
Moderna spikes 11% to record highs after it is selected to be added to S&P 500
Alexion Therapeutics, which is set to be acquired by AstraZeneca, will be replaced by Moderna in th…